PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
October 1, 2013Clinical Cancer Research

CTLA-4 and PD-1/PD-L1 Blockade: New Immunotherapeutic Modalities with Durable Clinical Benefit in Melanoma Patients

View Full Paper
Ask AI
Bookmark
Share

Authors

POPatrick A. OttFHF. Stephen HodiCRCaroline Robert

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ott et al. (2013) studied this question.

synapsesocial.com/papers/69dbecf9d60f0b8828835bd5https://doi.org/10.1158/1078-0432.ccr-13-0143
View Full Paper
Ask AI
Bookmark
Share